Top news of the week: 06.10.2020.

#AgBiotech #agtech #news #pharma #pharmiweb

Career And Jobs

On Oct 6, 2020
@GENbio shared
RT @IAmBiotech: #AgBiotech is attracting significant investment--mainly due to the rise of young, innovative startups that often bring to the table fresh ideas and new technological advances. Find out more: https://t.co/z2C6In3B1x #agtech https://t.co/jV5vx9piEp
Open

Ag Biotech Poised to Start a New Green Revolution

Ag Biotech Poised to Start a New Green Revolution

Facing diminishing resources, climate change, and hungrier populations, agriculture is trying new tools such as POC testing, microbiome management, and post-GMO crop development.

On Oct 1, 2020
@IAmBiotech shared
Excellent op-ed from @KYAgCommish Ryan Quarles on animal biotech, One Health, and a more resilient world. https://t.co/G5Fe96aUIS
Open

Opinion: A Healthy and resilient world needs animal biotech innovation

Opinion: A Healthy and resilient world needs animal biotech innovation

Ryan Quarles, Kentucky Agriculture Commissioner and President of the National Association of State Departments of Agriculture, discusses the need of animal biotechnology to create a healthy ...

On Sep 29, 2020
@JohnCendpts shared
Hooked by the science, Arie Belldegrun joins a group of influentials who believe Dewpoint may have the key to the next big thing in biotech https://t.co/WInbQT67X9
Open

Hooked by the science, Arie Belldegrun joins a group of influentials who believe Dewpoint may have the key to the next big thing in biotech

Hooked by the science, Arie Belldegrun joins a group of influentials who believe Dewpoint may have the key to the next big thing in biotech

Amir Nashat knew he had years of preclinical work to do when he talked to me at the beginning of 2019 about Dewpoint Therapeutics and its rare focus on the role bimolecular condensates ...

On Sep 30, 2020
@JohnCendpts shared
Norbert Bischofberger, Kronos: I’ve done it and seen it all, now I want to apply it to my own ideas.” https://t.co/mjbSX5TDnB
Open

The Endpoints 11: Here are some of the most promising startups in biotech. And Covid-19 isn't going to stop them

The Endpoints 11: Here are some of the most promising startups in biotech. And Covid-19 isn't going to stop them

Quite often when I highlight a private, typically early-stage biotech company for these annual awards, I’m asked what I look for in a company. How do you define an Endpoints 11 company? ...

On Oct 1, 2020
@JohnCendpts shared
In which we connect several dots -- After recruiting an AstraZeneca vet as CEO to head a new team and raising $139M cash, little Olema appears to be ready to launch … something https://t.co/ouqXUa8XkP
Open

After recruiting an AstraZeneca vet as CEO to head a new team and raising $139M cash, little Olema appears to be ready to launch … something

After recruiting an AstraZeneca vet as CEO to head a new team and raising $139M cash, little Olema appears to be ready to launch … something

Sean Bohen is managing his re-entry into the R&D world in style. And he's swerving straight into the fast lane. A couple of weeks after we chatted about the end of his sabbatical following ...

On Oct 1, 2020
@JohnCendpts shared
AMAG tops its year-long, activist driven transformation with a $647M selloff to private equity By @Jasonmmast https://t.co/WsZp1HOXW0
Open

AMAG tops its year-long, activist driven transformation with a $647M selloff to private equity

AMAG tops its year-long, activist driven transformation with a $647M selloff to private equity

AMAG Pharmaceuticals, beset by falling revenue and the threat of the FDA pulling a longtime drug, has spent the last year trying to streamline, cutting staff and jettisoning assets to other ...

On Oct 5, 2020
@JohnCendpts shared
Big trend here: Harvard 'MacArthur genius’ Kevin Eggan steps in to run early-stage research at rare disease specialist BioMarin $BMRN https://t.co/cl1RdemBPI
Open

Harvard 'MacArthur genius’ Kevin Eggan steps in to run early-stage research at rare disease specialist BioMarin

Harvard 'MacArthur genius’ Kevin Eggan steps in to run early-stage research at rare disease specialist BioMarin

Pioneering ALS researcher Kevin Eggan has a new gig. After holding a tenured position at Harvard while working at the Broad and playing a founder’s role in launching 3 biotechs, Eggan is ...

On Sep 30, 2020
@pharminews shared
Global White Biotechnology Market Trends, Value, Growth Opportunities and Future Prospects | Dow AgroSciences LLC, Syngenta AG, KWS SAAT AG https://t.co/Ifi1LzlrQA #news #pharma #pharmiweb
Open

Global White Biotechnology Market Trends, Value, Growth Opportunities and Future Prospects | Dow AgroSciences LLC, Syngenta AG, KWS SAAT AG

Global White Biotechnology Market Trends, Value, Growth Opportunities and Future Prospects | Dow AgroSciences LLC, Syngenta AG, KWS SAAT AG

Pune, Maharashtra, India, September 30 2020 (Wiredrelease) MarketResearch.Biz –:The Global White Biotechnology Market Outlook to 2029, Capacity, Generation, Investment Trends, laws, and ...